WALNUT CREEK, CA-MetLife has acquired Treat Towers, a two-building, 10-story, class-A, LEED-EB Gold-certified office complex here, from an Equity Office Properties joint venture. MetLife declined to reveal the sale price to GlobeSt.com, but industry sources unrelated to the deal say it is rumored to be $130.4 million. Located at 1255 and 1277 Treat Blvd., the property comprises 378,000 square feet.
The acquisition marks an expansion of MetLife’s investment portfolio into the San Francisco Bay Area. Joel Redmon, Jacqueline Denning and Leslie Smith of MetLife’s San Francisco regional office led the acquisition effort, and HFF represented the seller in the transaction. According to Denning, “Treat Towers is an outstanding asset. This property fits very well with our strategy of buying and holding core assets in top-tier markets. We’re pleased to be able to add Treat Towers to our strong, well-diversified portfolio of commercial real estate.”
The buildings, which are connected by a plaza, are located near Interstate 680 and provide direct access to extensive public and private transportation. Within one block of the Pleasant Hill/Contra Costa Centre BART station, the property also contains a parking facility with six levels of covered parking to serve more than 1,100 vehicles. On-site amenities include a fitness center, conference center with a fully equipped training room and a professional board room, an ATM in both buildings, banking facilities and a full-service caf
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.